CClinicalTrials.gg
CompletedNCT02033174Updated Mar 10, 2017Results posted

Effects of Alcoholic Beverages in Pro-inflammatory and Antioxidant Profile After an Oral Fat Diet

An interventional study of Oral fat diet plus water with sugar and Oral fat diet plus alcoholic beverages in Alcohol Consumption, sponsored by Instituto de Investigación Sanitaria Gregorio Marañón. Completed at 1 site in Spain. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-03-10.

Sponsored by Instituto de Investigación Sanitaria Gregorio Marañón · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Non-randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

Hypothesis: Red wine intake but not other alcoholic beverages together with a fat diet will decrease inflammatory factors and lipid peroxidation and decrease antioxidant capacity in healthy people after a five days period.

02

Conditions studied

  • Alcohol Consumption

Browse trials for

Keywords

  • alcohol, inflammation, oxidation.
03

In context

Alcohol Drinking

925 studies on the registry are indexed under Alcohol Drinking; 172 are open to participants now.

This study's enrollment of 16 is below the median of 108 across 802 interventional studies indexed under Alcohol Drinking.

Browse Alcohol Drinking studies →

Lead sponsor

Instituto de Investigación Sanitaria Gregorio Marañón is the lead sponsor of 4 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy volunteers

Exclusion criteria

Exclusion Criteria:

  • Individuals with a plasma cholesterol level > 220 mg/dl
  • Smokers
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
16 participants (actual)

Study arms

  • Other
    Sugar water first, then alcohol

    8 participants have received oral fat diet plus water with sugar (equivalent caloric intakes as sugar with water in the control group). Then they receive the same oral fat-enriched diet (1486 kcal/m2) with 654 kcal/m2 (44%) as fat and a daily total amount of 16 g/m2 of alcohol, of different beverages (red wine, vodka, brandy or rum)

    Other: Oral fat diet plus water with sugar · Other: Oral fat diet plus alcoholic beverages

  • Other
    Alcohol first then sugar water

    8 participants have received oral fat diet plus alcoholic beverages (a daily total amount of 16 g/m2 of alcohol, of different beverages : red wine, vodka, brandy or rum). Then they receive the same oral fat-enriched diet (1486 kcal/m2) with 654 kcal/m2 (44%) as fat and water with sugar (equivalent caloric intakes as sugar with water in the control group).

    Other: Oral fat diet plus water with sugar · Other: Oral fat diet plus alcoholic beverages

Interventions

  • OtherOral fat diet plus water with sugar

    All participants were assigned to receive and oral fat diet plus sugar water. Oral fat diet contained 1487 kcal/m2 with 654 kcal/m2 (44%) as fat. Sugar water has equivalent caloric intakes as alcoholic beverages.

  • OtherOral fat diet plus alcoholic beverages

    Oral fat diet contained 1487 kcal/m2 with 654 kcal/m2 (44%) as fat. In all cases, alcohol represented a daily total amount of 16 g/m2. The content of alcohol was 12% in red wine, 37% in rum, and 35% in brandy.Vodka was tri-distilled and contained 40% alcohol.

06

What researchers measure

Primary outcomes

  1. Change From Baseline in Concentrations of Antioxidant Profile After Red Wine Intake

    In order to determine total antioxidant capacity a quantitative immunoassay using commercial kits (R\&D Systems, Inc. Minneapolis, USA) was conducted.

    Time frame: Baseline and 5 days

07

Results

Posted Oct 26, 2016

Participant flow

First Intervention
Participant flow — First Intervention
MilestoneAlcohol First, Then Sugar WaterSugar Water First ,Then Alcohol
Started88
Completed88
Not completed00
Washout (1 Week)
Participant flow — Washout (1 Week)
MilestoneAlcohol First, Then Sugar WaterSugar Water First ,Then Alcohol
Started88
Completed88
Not completed00
Second Intervention
Participant flow — Second Intervention
MilestoneAlcohol First, Then Sugar WaterSugar Water First ,Then Alcohol
Started88
Completed88
Not completed00

Outcome measures

PrimaryChange From Baseline in Concentrations of Antioxidant Profile After Red Wine Intake

In order to determine total antioxidant capacity a quantitative immunoassay using commercial kits (R\&D Systems, Inc. Minneapolis, USA) was conducted.

Time frame:
Baseline and 5 days
Reported as:
Median · percentage of change in TAC
Change From Baseline in Concentrations of Antioxidant Profile After Red Wine Intake
percentage of change in TACAlcoholic Beverages (Red Wine Intake)Oral Fat Diet
Change From Baseline in Concentrations of Antioxidant Profile After Red Wine Intake22.3 (19.7 to 25.9)12.7 (8.1 to 20.3)
Statistical analysis
  • Alcoholic Beverages (Red Wine Intake) vs Oral Fat Diet · Kruskal-Wallis · p = 0.05

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Alcoholic Beverages—0/16 (0%)0/16 (0%)
Oral Fat Diet—0/16 (0%)0/16 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)All Participants
<=18 years0
Between 18 and 65 years16
>=65 years0
Sex: Female, Male
Sex: Female, Male(Participants)All Participants
Female8
Male8
Race (NIH/OMB)
Race (NIH/OMB)(Participants)All Participants
American Indian or Alaska Native0
Asian0
Native Hawaiian or Other Pacific Islander0
Black or African American0
White16
More than one race0
Unknown or Not Reported0
08

Study locations

1 site
  • IiSGM
    Madrid, 28007, Spain
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 10, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02033174
Lead sponsor
Instituto de Investigación Sanitaria Gregorio Marañón
Responsible party
Luis A. Alvarez-Sala (MD, Instituto de Investigación Sanitaria Gregorio Marañón) — Principal investigator
First posted
Jan 10, 2014
Start date
Jan 2001
Primary completion
Jul 2001
Completion
Jul 2001
Results posted
Oct 26, 2016
Last update
Mar 10, 2017

Study contacts

Luis A Alvarez-Sala, PhD, MD
principal investigator · Head of section. Dep. of Internal Medicine

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion